New drug BT-114143 passes first safety check in healthy volunteers
NCT ID NCT07169240
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 25 times
Summary
This early-stage study tested a new drug called BT-114143 in 84 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects and drug levels in the blood. The goal was not to treat any disease, but to gather important safety information for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PKU Care Luzhong Hospital
Zibo, Shandong, 255499, China
Conditions
Explore the condition pages connected to this study.